H. Han

Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency.

Wei Huang, J. Sasaki, K. Arakawa, 1999, Arteriosclerosis, thrombosis, and vascular biology.

A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.

J. Sasaki, K. Arakawa, S. Horiuchi, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.

D. Sviridov, J. Sasaki, N. Fidge, 2001, Atherosclerosis.

A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.

Wei Huang, J. Sasaki, K. Arakawa, 2000, Arteriosclerosis, thrombosis, and vascular biology.

A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.

J. Sasaki, K. Arakawa, A. Matsunaga, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Evidence for a Novel Role of Copper-Zinc Superoxide Dismutase in Zinc Metabolism*

J. Valentine, E. B. Gralla, C. Srinivasan, 2001, The Journal of Biological Chemistry.

Structural and functional properties of apolipoprotein A-I mutants.

J. Sasaki, A. Matsunaga, T. Koga, 2000, Journal of atherosclerosis and thrombosis.